Bhagirathbhai Ravjibhai Dholaria MD
Hematologic Oncology
Associate Professor, Hematology-Oncology, Vanderbilt University Medical Center
Join to View Full Profile
2220 Pierce AveNashville, TN 37232
Phone+1 615-875-9731
Dr. Dholaria is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an associate professor in the department of hematology-oncology (Stem cell Transplant and Cellular Immunotherapy) at Vanderbilt University Medical Center and Nashville VA Medical Center. My area of specialization is hematological malignancies and stem cell transplantation. My primary field of research is adoptive cellular therapies (CAR T-cell therapy) for the treatment of relapsed lymphoid and plasma cell malignancies.
Education & Training
Moffitt Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2017 - 2018
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2014 - 2017
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2011 - 2014
B. J. Medical College AhmedabadClass of 2009
Certifications & Licensure
TN State Medical License 2018 - 2025
FL State Medical License 2014 - 2022
AL State Medical License 2020 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Conquer Cancer Foundation Merit Award ASCO, 2018
Clinical Trials
- Ruxolitinib + Allogeneic Stem Cell Transplantation in AML Start of enrollment: 2017 Nov 03
- COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide Start of enrollment: 2023 Jan 18
- HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide Start of enrollment: 2021 Sep 30
- Join now to see all
Publications & Presentations
PubMed
- Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial.Bhagirathbhai Dholaria, Shakthi T Bhaskar, Vivek G Patel, Eden Biltibo, Reena Jayani
Bone Marrow Transplantation. 2025-03-24 - Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.Zachariah DeFilipp, Haesook T Kim, Laura W Knight, Suzanne M O'Connor, Shilton E Dhaver
Blood. 2025-03-19 - 1 citationsEvaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.Joseph F Mort, David Brighton, Samantha DiBenedetto, Leah Wells, Stephen M Clark
European Journal of Haematology. 2025-03-01
Journal Articles
- CMV esophagitis: sequelae of radiation therapyKhetpal R, Arnaoutakis K, Dholaria B, Esophagus
- The great imitator: Psychosis that responded to penicillinDholaria B, Pant S, Lavender R, Agarwal A, Canadian Family Physicians
Press Mentions
‘Off-the-Shelf’ CAR T Therapy Shows Promise for relapsed/refractory Multiple MyelomaOctober 4th, 2024- Roche-Poseida Lead Allogeneic CAR-T Advances After Showing Promise in Multiple MyelomaOctober 2nd, 2024
- Poseida Therapeutics Presents Positive Early Results from Its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual MeetingDecember 13th, 2023
Professional Memberships
- Member
- American Society for Transplantation and Cellular TherapyMember
Other Languages
- Hindi, Gujarati
External Links
- VUMC healthhttps://search.vanderbilthealth.com/doctors/dholaria-bhagirathbhai
- VUMChttps://medicine.vumc.org/person/bhagirathbhai-dholaria-mbbs
- VICChttps://www.vicc.org/member/bhagi-dholaria
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
